A fertility services provider says it is seeing “lower activity” in Australia’s IVF market, reporting lower volumes in stimulated fertility cycles. The statement comes from the company that, according to reports, has twice rejected takeover offers over the past year. The outlets agree that the key operational change being highlighted is a reduction in stimulated cycle volume, which indicates a softer level of demand or reduced throughput in the IVF segment. While the articles focus on the company’s assessment of market conditions, they do not provide detailed figures, timelines, or explicit causes for the decline in stimulated cycle volumes. The reporting also frames the announcement in the context of the company’s prior responses to acquisition interest, noting its decision to reject takeover proposals. Overall, the coverage presents a consistent picture: the provider cites a decline in IVF activity in Australia and does so while remaining in control of the business after previously turning down bidders.